14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
May 27, 2022 $182.50 $182.50 $182.50 $182.50 0
May 26, 2022 $182.50 $182.50 $182.50 $182.50 0
May 25, 2022 $182.50 $182.50 $182.50 $182.50 0
May 24, 2022 $182.50 $182.50 $182.50 $182.50 0
May 23, 2022 $182.50 $182.50 $182.50 $182.50 0
May 20, 2022 $182.50 $182.50 $182.50 $182.50 0
May 19, 2022 $182.50 $182.50 $182.50 $182.50 0
May 18, 2022 $182.50 $182.50 $182.50 $182.50 0
May 17, 2022 $182.50 $182.50 $182.50 $182.50 0
May 16, 2022 $182.50 $182.50 $182.50 $182.50 0
May 13, 2022 $182.50 $182.50 $182.50 $182.50 0
May 12, 2022 $182.50 $182.50 $182.50 $182.50 0
May 11, 2022 $182.50 $182.50 $182.50 $182.50 0
May 10, 2022 $182.50 $182.50 $182.50 $182.50 0
May 09, 2022 $182.50 $182.50 $182.50 $182.50 0
May 06, 2022 $182.50 $182.50 $182.50 $182.50 0
May 05, 2022 $182.50 $182.50 $182.50 $182.50 0
May 04, 2022 $182.50 $182.50 $182.50 $182.50 0
May 03, 2022 $182.50 $182.50 $182.50 $182.50 0
May 02, 2022 $182.50 $182.50 $182.50 $182.50 0
Apr 29, 2022 $182.50 $182.50 $182.50 $182.50 0
Apr 28, 2022 $182.50 $182.50 $182.50 $182.50 0
Apr 27, 2022 $182.50 $182.50 $182.50 $182.50 0
Apr 26, 2022 $182.50 $182.50 $182.50 $182.50 0
Apr 25, 2022 $182.50 $182.50 $182.50 $182.50 0
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT